BLISSGVS / NSE / Biotechnology & Drugs
Bliss GVS Pharma
1Y Price Trend
Key Information
Recommendations
Target High552.9
Target Low118.35
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk57.91
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Anupam Rasayan acquires Mates Visa for Bliss GVS deal scanx.trade
Bliss GVS Pharma (506197) Q2 25/26 earnings summary Quartr
Bliss GVS Pharma declares Re. 1.00 final dividend for FY26 scanx.trade
Bliss GVS Pharma Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 marketscreener.com
Bliss GVS Pharma - Multibaggers: 13 stocks surged up to 225% in just 3 months The Economic Times
Anupam Rasayan delivers record FY26 revenue surge as global expansion gains pace Indian Chemical News
Stock FAQs
What is the symbol and ISIN of Bliss GVS Pharma?
Bliss GVS Pharma has the symbol BLISSGVS and ISIN - INE416D01022.
What is the current price of Bliss GVS Pharma?
Bliss GVS Pharma is currently trading at INR 483.50.
What are the year high and year low of Bliss GVS Pharma?
Bliss GVS Pharma has a year high of INR 552.90 and a year low of INR 118.35.
What is the market capitalization of Bliss GVS Pharma?
Bliss GVS Pharma has a market capitalization of INR 5,142.67 crore.
What is the P/E ratio of Bliss GVS Pharma?
Bliss GVS Pharma has a P/E ratio of 17.63.
What is the dividend yield of Bliss GVS Pharma?
Bliss GVS Pharma has a dividend yield of 0.30%.
How is the financial performance of Bliss GVS Pharma based on revenue, net income, and EPS?
Bliss GVS Pharma has revenue of INR 9,271.13 crore, net income of INR 1,291.29 crore, and EPS of INR 12.14.
What is the book value of Bliss GVS Pharma?
Bliss GVS Pharma has a book value of INR 112.01.
What is the debt-to-equity ratio of Bliss GVS Pharma?
Bliss GVS Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Bliss GVS Pharma?
Bliss GVS Pharma has a price-to-book ratio of 4.32 and a price-to-sales ratio of 0.55.
© SharekeyX | Rusaka Technologies 2024-2026